Serial assessments of cognition, mood, and disability were carried out at nine month intervals over a 54 month period on a cohort of 87 patients with Parkinson's disease (PD) and a matched cohort of 50 control subjects. Dementia was diagnosed from data by rigorously applying DSM-III-R criteria. Initially, 6% (5187) PD patients were demented, compared with none of the 50 control subjects. A further 10 PD patients met the dementia criteria during the follow up period; this was equivalent, with survival analysis, to a cumulative incidence of 190%.. With the number of person years of observation as the denominator, the incidence was 47*6I1000 person years of observation.
Estimates of the prevalence of dementia in Parkinson's disease (PD) have varied widely and range from 0% to 81%. 2 Brown and Marsden have argued convincingly that this variation is due to methodological inconsistencies between studies.3 Much of the inconsistency has resulted from the use of a variety of definitions and methods of identifying dementia. The use of standard criteria for diagnosis of dementia has improved consistency in reported prevalence; for example, studies using DSM-III criteria4 report prevalences between 1 1 % and 15%. 5- A further difficulty relates to study design. Virtually all studies that have examined dementia in PD have been either retrospective reviews of case notes, which depend on the quality of the case notes, or single cross sectional assessments, which pose problems of interpretation. Poor performance on cognitive testing on a single occasion could result from factors other than dementia, such as the effects of medication or mood disturbance. In addition, some patients perform badly on cognitive testing as a result of low premorbid intelligence rather than a decline due to dementia. Some investigators have attempted to provide evidence of decline by showing a discrepancy between estimates of premorbid intelligence and current intelligence.89 This is only an indirect way of showing decline and, because no instrument for estimating premorbid intelligence has yet been validated for use in PD, results may be misleading.
Serial assessments of patients can overcome these difficulties. Firstly, poor performance on cognitive testing on a single occasion may be seen to be transient, in which case dementia is unlikely to be the cause. Secondly, decline can be directly observed rather than inferred from the use of unvalidated tests of premorbid intelligence. Thirdly, cross sectional assessment can give only an estimate of prevalence of dementia in PD but serial assessments can enable the incidence of dementia to be estimated and may provide information about the evolution and prognosis of dementia in PD.
Mayeux et We carried out longitudinal assessments of cognition, mood, and disability at nine month intervals over a 54 month follow up period on a cohort of patients with PD and a matched cohort of control subjects. On the basis of the data we judged whether DSM-III-R dementia was present in each subject and, if present, when it occurred. We present our findings in the form of a survival analysis.
Patients and method Subjects Most patients included in the study came from a single local neurological clinic (at Leeds General Infirmary). These comprised all existing patients and consecutive new referrals with a diagnosis of idiopathic PD. None refused to take part in the study. A few patients were volunteers from other local neurological clinics. Patients were seen by members of the research team; they were considered suitable for inclusion to the study if they had at least two of the three major features of PD (rigidity, tremor, and bradykinesia), a history of insidious onset and progression of symptoms, and none of the following exclusion criteria: 1) history of stroke, transient ischaemic attack, hypertension, syphilis, encephalitis, epilepsy, cerebral tumour, alcoholism, diabetes mellitus, or head injury resulting in loss of consciousness; 2) presence or history of any neurological sign not compatible with a diagnosis of PD (such as cerebellar signs, supranuclear gaze palsy, oculogyric crises); 3) presence and any illness associated with chronic confusional states or of any chronic disabling disease other than PD; 4) surgery in the past six months or neuroleptic drugs in the past three months. Healthy control subjects, individually matched for age and sex to the first 50 PD patients, were recruited from spouses and other relatives of patients or from general practice or a local day centre for the elderly. Test (NART) ' was administered at the first assessment only. The rationale for the use of these tests has been fully discussed elsewhere. 20 Subjects were assessed, according to their preference, in their own homes or in the research office in the department ofpsychiatry; almost all were assessed at home. The testing took 90-120 minutes to complete. Subjects were assessed at nine month intervals from the initial assessment. The diagnosis of idiopathic PD was reviewed on each occasion. For the purposes of this presentation, only data collected up to the "closing date" of 31 August 1990 were used, although the assessment of subjects continues.
Assessment

Identification of dementia
No diagnoses of dementia were made until after the "closing date" of 31 August 1990, when data were examined. DSM-III-R criteria for the diagnosis of dementia were used.2' (The dementia criteria of DSM-III-R are virtually identical to those of DSM-III). For such a diagnosis to be made there must have been impairment of short and long term memory (criterion A) and also impairment of at least one other area of "higher cortical function" (criterion B). Examples given include: impaired abstract memory, impaired judgment, aphasia, apraxia, agnosia, constructional difficulty, and personality change. Criteria A and B therefore identified subjects who had possible dementia on the basis of formal cognitive testing, although little guidance has been given as to what tests should be used and what constitutes "impairment." The remaining criteria require that "the disturbance" (as defined by criteria A and B) interferes significantly with occupational or social functioning (criterion C), that it is not due solely to delirium (criterion D), and that either an aetiological organic factor can be implicated or that the disturbance is not due to non-organic mental illness (criterion E). Thus criteria C, D, and E need subjective judgments to be made on the basis of unquantifiable but detailed knowledge of the subject in order to confirm or refute the diagnosis of dementia. We have therefore applied DSM-III-R dementia criteria as follows.
For each subject a data summary sheet was prepared. Each sheet contained the data obtained from each of the serial assessments made on a given subject on the following tests: seven WAIS subtests (the six from the verbal scale and the picture completion subtest), the logical memory and associate learning subtests of the WMS, the NART, the MMSE and the GNT. All the available data for each subject were displayed on a single sheet. Data were arranged on each sheet so that all the results for an assessment were represented as a row of data (with the initial assessment comprising the top row, and subsequent assessments forming successive rows below). Results for each test thus formed columns, allowing easy comparison of test performances between assessments in a given individual. This arrangement facilitated the identification of subjects whose test performance deteriorated progressively. Subjects showing deterioration on tests at one or more visits but with subsequent recovery on further assessment were unlikely to be mistakenly identified as demented.
Two independent raters were each given the data summary sheets for all subjects in the study along with a copy of the DSM-III-R diagnostic criteria. Both rathers were experienced clinicians but from different disciplines: one was a psychiatrist and the other a clinical psychologist. The data sheets were prepared in such a way that the raters were blind as to which subjects were PD patients and which were control subjects. The raters were required to decide on the basis of the data whether each subject met both criterion A and criterion B (as a forced choice task) and if so at which assessment these criteria were first met. The raters were also invited to write down any comments they had for each subject. Subjects identified by these blind raters as meeting criteria A and B were further evaluated by two The three other studies that have used DSM-III criteria have reported prevalences of dementia in PD between 11% and 15%.5-7 When DSM-III criteria were applied to data from seven previous hospital based studies, Lees found a range of prevalence of dementia in PD of 7-15%; in four community based studies the range was 3-14%.7 Our estimate of prevalence is the lowest so far reported for a hospital based study using DSM-III criteria. There are two possible reasons for this. Firstly, the longitudinal design of our study minimises the risk of false identification of dementia due a single poor test performance. Secondly, as described in the methods section, we took particular care in applying the DSM-III criteria.
The estimate of a cumulative incidence of dementia of 19% over a 54 month follow up period in our PD cohort can be expressed in terms of number of person years of observation. We found an incidence of 47-6/1000 person years of observation. Mayeux et al estimated the incidence to be 69/1000 person years of observation but used a different methodology and had an older cohort of PD patients (mean 71-4 years compared to 64 1 years in our study). 10 Differences between subjects who withdraw and those who do not may lead to bias in the results. It is probable that some subjects refused testing because they found the procedure too arduous, possibly as a result of early cognitive impairment; we (11 PD patients, six control subjects) the raters noted some cognitive impairment, although it was insufficient to meet the criteria. Further follow up may determine whether these subjects were in the early stages of dementia. Follow up of subjects is continuing and as subjects die their brains are being collected for neuropathological study. This is the first prospective study to estimate the incidence of dementia in PD. Our finding of an incidence of 19% in 54 months is striking and contradicts suggestions, based on prevalence rates, that the risk of global dementia in patients with PD is only slightly greater than that in the general population.79
